Exchange Bank’s Pfizer PFE Stock Holding History

Exchange Bank’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$554K	Sell	23,020 -2,262	-9%	-$59.2K	0.35%	80
2026 Q1	$710K	Hold	25,282	–	–	0.49%	64
2025 Q4	$630K	Sell	25,282 -2,022	-7%	-$51K	0.44%	68
2025 Q3	$696K	Buy	27,304 +6,399	+31%	+$158K	0.48%	61
2025 Q2	$507K	Sell	20,905 -3,014	-13%	-$70.3K	0.4%	75
2025 Q1	$606K	Sell	23,919 -188	-0.8%	-$4.92K	0.49%	59
2024 Q4	$640K	Buy	24,107 +214	+0.9%	+$5.8K	0.51%	59
2024 Q3	$691K	Hold	23,893	–	–	0.57%	52
2024 Q2	$669K	Sell	23,893 -1,177	-5%	-$32.4K	0.57%	51
2024 Q1	$696K	Sell	25,070 -3,170	-11%	-$88K	0.57%	50
2023 Q4	$813K	Sell	28,240 -2,033	-7%	-$61.5K	0.7%	41
2023 Q3	$1M	Sell	30,273 -300	-1%	-$10.6K	0.96%	31
2023 Q2	$1.12M	Buy	+30,573	New	+$1.19M	1.08%	29

Other funds holding PFE

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Welch Group Birmingham, Alabama $2.93B AUM 27.62% 1-Year Est. Return

Exchange Bank's PFE Position: Q2 2026 in Review

Exchange Bank reduced its Pfizer (PFE) stake by 8.9% in Q2 2026, selling an estimated $59.2K and leaving 23,020 shares worth $554K. The position accounts for 0.35% of the portfolio, ranked #80.

Exchange Bank first reported a position in PFE in Q2 2023 and has held it in 13 quarters since. The position peaked at $1.12M in Q2 2023. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Exchange Bank held 23,020 shares of Pfizer worth $554K as of Q2 2026.
Exchange Bank sold 2,262 Pfizer shares in Q2 2026, an estimated $59.2K.
Pfizer made up 0.35% of Exchange Bank's portfolio in Q2 2026, its #80 holding.
Exchange Bank first reported a position in Pfizer in Q2 2023 and has held it in 13 quarters since.
Exchange Bank's Pfizer position peaked at $1.12M in Q2 2023.
900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Exchange Bank's 13F filing for Q2 2026, filed 9 Jul 2026.